Crofelemer

FDA Drug Profile — MYTESI

Drug Details

Generic Name
Crofelemer
Brand Names
MYTESI
Application Number
NDA202292
Sponsor
Indena SpA
NDC Codes
2
Dosage Forms
POWDER, TABLET, COATED
Routes
ORAL
Active Ingredients
CROFELEMER

Indications and Usage

1 INDICATIONS AND USAGE MYTESI is indicated for symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. MYTESI is an anti-diarrheal indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. ( 1 )